Overview Financials News + Filings Key Docs Charts Ownership Insiders
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Quarterly results
Director departure
|
|
Principia Biopharma Inc. (PRNB)
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 02/16/2021 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 11/24/2020 |
GN
| Patient Enrollment Concluded Early in PEGASUS Phase 3 Pemphigus Trial for Rilzabrutinib |
| 10/08/2020 |
15-12B
| Form 15-12B - Securities registration termination [Section 12(b)]: |
| 09/30/2020 |
SC 13D/A
| Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend] |
| 09/30/2020 |
EFFECT
| Form EFFECT - Notice of Effectiveness: |
| 09/28/2020 |
4
| Tomasello Shawn (Director) has filed a Form 4 on Principia Biopharma Inc.|
Txns:
| Disposed/sold 20,475 options to buy
@ $36.79, valued at
$753.3k
Disposed/sold 10,240 options to buy
@ $62.66, valued at
$641.6k
|
|
| 09/28/2020 |
4
| Machado Patrick (Director) has filed a Form 4 on Principia Biopharma Inc.|
Txns:
| Disposed/sold 20,475 options to buy
@ $31.77, valued at
$650.5k
Disposed/sold 10,240 options to buy
@ $31.77, valued at
$325.3k
Disposed/sold 10,240 options to buy
@ $62.66, valued at
$641.6k
|
|
| 09/28/2020 |
4
| George Simeon (Director) has filed a Form 4 on Principia Biopharma Inc.|
Txns:
| Unknown transaction of 2,982,855 shares
@ $100, valued at
$298.3M
Disposed/sold 28,623 warrants
@ $0
Disposed/sold 20,475 options to buy
@ $0
Disposed/sold 10,240 options to buy
@ $0 |
|
| 09/28/2020 |
4
| Lin Shao-Lee (Director) has filed a Form 4 on Principia Biopharma Inc.|
Txns:
| Disposed/sold 20,475 options to buy
@ $27.81, valued at
$569.4k
Disposed/sold 10,240 options to buy
@ $31.77, valued at
$325.3k
Disposed/sold 10,240 options to buy
@ $62.66, valued at
$641.6k
|
|
| 09/28/2020 |
4
| Becker Daniel J. (Director) has filed a Form 4 on Principia Biopharma Inc.|
Txns:
| Unknown transaction of 667,600 shares
@ $100, valued at
$66.8M
Disposed/sold 20,475 options to buy
@ $17, valued at
$348.1k
Disposed/sold 10,240 options to buy
@ $31.77, valued at
$325.3k
Disposed/sold 10,240 options to buy
@ $62.66, valued at
$641.6k
|
|
| 09/28/2020 |
4
| Colowick Alan (Director) has filed a Form 4 on Principia Biopharma Inc.|
Txns:
| Disposed/sold 47,724 options to buy
@ $4.542, valued at
$216.8k
Disposed/sold 20,475 options to buy
@ $17, valued at
$348.1k
Disposed/sold 10,240 options to buy
@ $31.77, valued at
$325.3k
Disposed/sold 10,240 options to buy
@ $62.66, valued at
$641.6k
|
|
| 09/28/2020 |
4
| Wolff Stefani (Chief Development Officer) has filed a Form 4 on Principia Biopharma Inc.|
Txns:
| Gifted 5,504 shares
@ $0
Unknown transaction of 13,592 shares
@ $100, valued at
$1.4M
Disposed/sold 30,056 options to buy
@ $4.542, valued at
$136.5k
Disposed/sold 16,843 options to buy
@ $7.2671, valued at
$122.4k
Disposed/sold 22,017 options to buy
@ $11.3549, valued at
$250k
Disposed/sold 55,042 options to buy
@ $17, valued at
$935.7k
Disposed/sold 60,000 options to buy
@ $35.42, valued at
$2.1M
Disposed/sold 55,000 options to buy
@ $67.31, valued at
$3.7M
|
|
| 09/28/2020 |
4
| Thomas Dolca (Chief Medical Officer) has filed a Form 4 on Principia Biopharma Inc.|
Txns:
| Unknown transaction of 2,207 shares
@ $100, valued at
$220.7k
Disposed/sold 168,057 options to buy
@ $23.77, valued at
$4M
Disposed/sold 60,000 options to buy
@ $35.42, valued at
$2.1M
Disposed/sold 55,000 options to buy
@ $67.31, valued at
$3.7M
|
|
| 09/28/2020 |
4
| Hardiman Roy C. (Chief Business Officer) has filed a Form 4 on Principia Biopharma Inc.|
Txns:
| Unknown transaction of 117,761 shares
@ $100, valued at
$11.8M
Unknown transaction of 1,916 shares
@ $100, valued at
$191.6k
Disposed/sold 11,519 options to buy
@ $7.2671, valued at
$83.7k
Disposed/sold 44,034 options to buy
@ $11.3549, valued at
$500k
Disposed/sold 60,000 options to buy
@ $35.42, valued at
$2.1M
Disposed/sold 55,000 options to buy
@ $67.31, valued at
$3.7M
|
|
| 09/28/2020 |
4
| CHAI CHRISTOPHER Y (CFO) has filed a Form 4 on Principia Biopharma Inc.|
Txns:
| Unknown transaction of 3,799 shares
@ $100, valued at
$379.9k
Unknown transaction of 3,302 shares
@ $100, valued at
$330.2k
Disposed/sold 56,982 options to buy
@ $2.9977, valued at
$170.8k
Disposed/sold 24,769 options to buy
@ $3.1794, valued at
$78.8k
Disposed/sold 29,723 options to buy
@ $4.7236, valued at
$140.4k
Disposed/sold 13,210 options to buy
@ $4.9961, valued at
$66k
Disposed/sold 34,677 options to buy
@ $7.2671, valued at
$252k
Disposed/sold 44,034 options to buy
@ $11.3549, valued at
$500k
Disposed/sold 60,000 options to buy
@ $35.42, valued at
$2.1M
Disposed/sold 55,000 options to buy
@ $67.31, valued at
$3.7M
|
|
| 09/28/2020 |
4
| Goldstein David M (Chief Scientific Officer) has filed a Form 4 on Principia Biopharma Inc.|
Txns:
| Unknown transaction of 31,826 shares
@ $100, valued at
$3.2M
Disposed/sold 12,960 options to buy
@ $3.1794, valued at
$41.2k
Disposed/sold 13,210 options to buy
@ $4.7236, valued at
$62.4k
Disposed/sold 8,807 options to buy
@ $4.7236, valued at
$41.6k
Disposed/sold 15,412 options to buy
@ $4.9961, valued at
$77k
Disposed/sold 22,017 options to buy
@ $4.9961, valued at
$110k
Disposed/sold 34,677 options to buy
@ $7.2671, valued at
$252k
Disposed/sold 44,034 options to buy
@ $11.3549, valued at
$500k
Disposed/sold 60,000 options to buy
@ $35.42, valued at
$2.1M
Disposed/sold 75,000 options to buy
@ $67.31, valued at
$5M
|
|
| 09/28/2020 |
4
| Babler Martin (President, CEO) has filed a Form 4 on Principia Biopharma Inc.|
Txns:
| Unknown transaction of 1,023 shares
@ $100, valued at
$102.3k
Unknown transaction of 39,179 shares
@ $100, valued at
$3.9M
Unknown transaction of 18,355 shares
@ $100, valued at
$1.8M
Disposed/sold 255 warrants
@ $8.9931, valued at
$2.3k
Disposed/sold 50,795 options to buy
@ $1.9076, valued at
$96.9k
Disposed/sold 85,728 options to buy
@ $2.9977, valued at
$257k
Disposed/sold 110,085 options to buy
@ $3.1794, valued at
$350k
Disposed/sold 83,004 options to buy
@ $4.7236, valued at
$392.1k
Disposed/sold 60,546 options to buy
@ $4.9961, valued at
$302.5k
Disposed/sold 115,590 options to buy
@ $7.2671, valued at
$840k
Disposed/sold 187,144 options to buy
@ $11.3549, valued at
$2.1M
|
|
| 09/28/2020 |
S-8 POS
| Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments: |
| 09/28/2020 |
S-8 POS
| Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments: |
| 09/28/2020 |
S-8 POS
| Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments: |
| 09/28/2020 |
POS AM
| Form POS AM - Post-Effective amendments for registration statement: |
| 09/28/2020 |
25-NSE
| Form 25-NSE - Notification filed by national security exchange to report the removal from listing and registration of matured, redeemed or retired securities: |
| 09/28/2020 |
8-K
| Completion of Acquisition or Disposition of Assets, Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Sta... |
| 09/28/2020 |
SC 14D9/A
| Form SC 14D9/A - Solicitation, recommendation statements: [Amend] |
| 09/28/2020 |
SC TO-T/A
| Form SC TO-T/A - Tender offer statement by Third Party: [Amend] |
| 09/22/2020 |
4
| Hardiman Roy C. (Chief Business Officer) has filed a Form 4 on Principia Biopharma Inc.|
Txns:
| Sold 5,000 shares
@ $99.9835, valued at
$499.9k
Exercised 2,758 options to buy
@ $4.7236, valued at
$13k
Exercised 2,242 options to buy
@ $7.2671, valued at
$16.3k
|
|
| 09/22/2020 |
SC 14D9/A
| Form SC 14D9/A - Solicitation, recommendation statements: [Amend] |
| 09/22/2020 |
SC TO-T/A
| Form SC TO-T/A - Tender offer statement by Third Party: [Amend] |
| 09/17/2020 |
SC 14D9/A
| Form SC 14D9/A - Solicitation, recommendation statements: [Amend] |
| 09/17/2020 |
GN
| Principia Announces First Patient Dosed in Phase 2A Trial of Rilzabrutinib in IgG4-Related Disease |
| 09/14/2020 |
SC TO-T/A
| Form SC TO-T/A - Tender offer statement by Third Party: [Amend] |
| 09/14/2020 |
SC 14D9/A
| Form SC 14D9/A - Solicitation, recommendation statements: [Amend] |
| 09/10/2020 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 09/02/2020 |
GN
| SHAREHOLDER ALERT: Rigrodsky & Long, P.A. Reminds Investors of Investigations of PRNB, CBMG, PFNX, and VAR Buyouts |
|
|
|